Convergence Investment Partners LLC Increases Stake in DaVita Inc. (NYSE:DVA)

Convergence Investment Partners LLC raised its position in DaVita Inc. (NYSE:DVA) by 33.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 11,389 shares of the company’s stock after purchasing an additional 2,836 shares during the period. Convergence Investment Partners LLC’s holdings in DaVita were worth $1,703,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DVA. Exchange Traded Concepts LLC purchased a new position in DaVita in the 3rd quarter valued at $135,000. Vontobel Holding Ltd. raised its holdings in shares of DaVita by 17.2% during the 3rd quarter. Vontobel Holding Ltd. now owns 2,243 shares of the company’s stock worth $368,000 after acquiring an additional 329 shares during the period. Capital Investment Advisors LLC purchased a new stake in DaVita in the 3rd quarter valued at about $213,000. Blue Trust Inc. raised its holdings in DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after buying an additional 119 shares during the period. Finally, Raymond James & Associates raised its holdings in DaVita by 93.6% in the 3rd quarter. Raymond James & Associates now owns 31,316 shares of the company’s stock valued at $5,134,000 after buying an additional 15,138 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $162.80.

DaVita Price Performance

Shares of NYSE DVA opened at $154.98 on Wednesday. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a twelve month low of $119.42 and a twelve month high of $179.60. The stock has a 50 day moving average of $161.41 and a two-hundred day moving average of $157.91. The stock has a market cap of $12.40 billion, a P/E ratio of 14.43, a P/E/G ratio of 0.79 and a beta of 0.94.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts forecast that DaVita Inc. will post 10.93 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.